Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVOID-DM: Pitavastatin + Ezetimibe vs Rosuvastatin in Prediabetic ASCVD Patients
NCT06767774Phase 4Recruiting
- Sponsor
- Korea University Anam Hospital
- Start
- Apr 2025
- Primary completion
- Aug 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pitavastatin, ezetimibe in atherosclerotic cardiovascular disease (ASCVD), sponsored by Korea University Anam Hospital. Started Apr 2025; status: recruiting.
02
Drugs
pitavastatinezetimibe
03
Conditions
atherosclerotic cardiovascular disease (ASCVD)
Beyond the preview
Go deeper on NCT06767774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06767774.